Advertisement

Advertisement

MAIA Stock Latest News

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

Company AnnouncementsMAIA Expands THIO-101 Lung Cancer Trial in U.S.

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

PremiumCompany Announcements

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

23d ago

MAIA Biotechnology secures funding for clinical trial of ateganosine

PremiumThe Fly

MAIA Biotechnology secures funding for clinical trial of ateganosine

23d ago

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

PremiumCompany Announcements

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

28d ago

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

PremiumCompany Announcements

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

1M ago

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

PremiumCompany AnnouncementsMAIA Showcases THIO-101 NSCLC Data at ELCC 2026

1M ago

MAIA Biotechnology Completes $30 Million Public Stock Offering

Company Announcements

MAIA Biotechnology Completes $30 Million Public Stock Offering

2M ago

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

The Fly

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

2M ago

MAIA Biotechnology announces common stock offering, no amount given

PremiumThe Fly

MAIA Biotechnology announces common stock offering, no amount given

2M ago

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

PremiumCompany Announcements

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

2M ago

MAIA Biotechnology published a 2026 Letter to Shareholders

PremiumThe Fly

MAIA Biotechnology published a 2026 Letter to Shareholders

2M ago

MAIA Biotechnology outlines 2026 goals for ateganosine program

PremiumCompany Announcements

MAIA Biotechnology outlines 2026 goals for ateganosine program

3M ago

MAIA Biotechnology highlights milestones, catalysts for FY26

PremiumThe FlyMAIA Biotechnology highlights milestones, catalysts for FY26

3M ago

MAIA Biotechnology Highlights Strategy in New Investor Presentation

Company Announcements

MAIA Biotechnology Highlights Strategy in New Investor Presentation

4M ago

MAIA Biotechnology directors participate in private placement financings

The Fly

MAIA Biotechnology directors participate in private placement financings

4M ago

MAIA Biotechnology Announces $2.25M Private Placement Deal

PremiumCompany Announcements

MAIA Biotechnology Announces $2.25M Private Placement Deal

4M ago

MAIA Biotechnology to sell 1.233M shares at $1.22 in private placement

PremiumThe Fly

MAIA Biotechnology to sell 1.233M shares at $1.22 in private placement

5M ago

MAIA Biotechnology announces $1.51M private placement

PremiumThe Fly

MAIA Biotechnology announces $1.51M private placement

5M ago

MAIA Biotechnology Announces Significant Insider Buying

PremiumCompany Announcements

MAIA Biotechnology Announces Significant Insider Buying

5M ago

MAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC

PremiumThe FlyMAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC

5M ago

MAIA Biotechnology CEO, board members acquire company shares

The Fly

MAIA Biotechnology CEO, board members acquire company shares

5M ago

MAIA Biotechnology Advances NSCLC Treatment with Ateganosine

Company Announcements

MAIA Biotechnology Advances NSCLC Treatment with Ateganosine

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >